Insider Trading activities of Cryolife Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cryolife Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cryolife Inc since year 2005. Table 2 shows the detailed insider transactions of Cryolife Inc since 2005. The reporting company's ticker symbol is CRY. The reporting company's CIK number is 784199.
The total value of stock buying since 2005 is $256,678.
The total value of stock sales since 2005 is $17,771,325.
The total value of stock option exercises since 2005 is $7,698,559.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Cryolife Inc (CRY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 2,000 $45,600 0 $0
2017-09 0 $0 126,000 $2,773,747 0 $0
2017-06 0 $0 9,577 $191,540 18,667 $95,575
2017-02 0 $0 11,083 $181,772 16,667 $116,835
2016-09 0 $0 0 $0 39,333 $283,613
2016-07 0 $0 2,000 $28,000 10,000 $70,100
2016-06 0 $0 10,000 $115,600 0 $0
2016-05 0 $0 5,000 $61,100 0 $0
2016-04 0 $0 1,000 $12,000 0 $0
2016-03 10,000 $109,130 2,000 $22,360 0 $0
2016-02 0 $0 23,000 $235,540 35,700 $172,431
2015-12 0 $0 700 $7,700 1,000 $4,830
2015-11 0 $0 11,800 $130,147 15,800 $76,313
2015-09 0 $0 9,198 $88,760 0 $0
2015-02 0 $0 30,000 $327,960 78,750 $766,237
2014-12 0 $0 3,900 $40,142 40,400 $387,787
2014-11 0 $0 34,211 $346,974 20,211 $126,662
2014-09 0 $0 30,000 $302,030 10,000 $51,200
2014-08 0 $0 36,000 $376,508 41,000 $262,519
2014-07 0 $0 26,977 $257,098 5,000 $24,150
2014-06 0 $0 2,500 $23,152 0 $0
2014-05 0 $0 56,345 $500,881 0 $0
2014-02 0 $0 0 $0 2,250 $19,575
2013-12 0 $0 0 $0 63,750 $554,625
2013-11 0 $0 161,501 $1,563,537 74,250 $629,472
2013-10 0 $0 7,000 $63,000 30,000 $252,499
2013-08 0 $0 15,000 $102,767 0 $0
2013-07 0 $0 0 $0 7,500 $36,225
2013-06 0 $0 4,000 $24,680 0 $0
2013-05 0 $0 2,250 $13,830 0 $0
2012-11 0 $0 10,360 $60,227 0 $0
2012-08 0 $0 3,000 $16,032 0 $0
2012-06 25,000 $119,825 3,000 $13,703 0 $0
2012-05 2,100 $10,283 10,000 $45,390 0 $0
2012-02 0 $0 5,000 $28,025 40,183 $232,859
2011-12 0 $0 3,000 $13,679 0 $0
2011-11 4,000 $17,440 15,000 $65,965 0 $0
2011-08 0 $0 0 $0 100,049 $425,207
2011-07 0 $0 401 $2,406 40,361 $171,534
2011-05 0 $0 34,000 $184,910 30,000 $150,000
2011-04 0 $0 0 $0 13,200 $66,300
2010-11 0 $0 12,000 $70,677 0 $0
2010-03 0 $0 7,500 $52,582 0 $0
2009-11 0 $0 0 $0 6,000 $32,160
2009-09 0 $0 500 $4,052 6,000 $32,160
2009-08 0 $0 42,962 $327,067 53,638 $262,295
2009-06 0 $0 27,637 $159,263 25,637 $135,103
2008-12 0 $0 0 $0 9,000 $48,240
2008-11 0 $0 25,000 $311,500 0 $0
2008-10 0 $0 0 $0 16,300 $75,935
2008-09 0 $0 25,601 $396,527 25,948 $180,148
2008-08 0 $0 139,928 $1,954,999 44,349 $271,952
2008-07 0 $0 5,500 $58,371 5,500 $34,155
2008-06 0 $0 8,500 $91,610 5,500 $34,155
2008-05 0 $0 67,550 $751,083 60,500 $281,228
2008-04 0 $0 5,500 $57,827 16,388 $108,955
2008-03 0 $0 24,605 $218,558 20,900 $158,840
2008-02 0 $0 17,714 $170,020 33,284 $73,224
2008-01 0 $0 5,000 $40,450 19,700 $43,340
2007-12 0 $0 0 $0 12,500 $27,500
2007-10 0 $0 0 $0 5,586 $18,014
2007-09 0 $0 28,000 $253,617 0 $0
2007-07 0 $0 9,000 $117,981 12,500 $27,500
2007-06 0 $0 23,004 $313,067 26,444 $159,751
2007-05 0 $0 177,680 $2,433,756 135,680 $411,476
2007-04 0 $0 14,675 $137,837 20,800 $74,880
2007-03 0 $0 12,600 $99,858 30,000 $66,000
2007-02 0 $0 8,000 $66,828 0 $0
2007-01 0 $0 8,000 $61,336 0 $0
2006-12 0 $0 28,000 $198,492 0 $0
2006-11 0 $0 33,000 $207,509 0 $0
2006-10 0 $0 8,000 $47,740 0 $0
2006-09 0 $0 39,500 $260,782 30,000 $66,000
2006-08 0 $0 76,500 $416,925 0 $0
2006-05 0 $0 25,000 $121,249 0 $0
2006-03 0 $0 25,000 $103,000 0 $0
2006-01 0 $0 0 $0 45,000 $99,000

Table 2. Detailed insider stock purchases, sales, and option exercises of Cryolife Inc insiders (CRY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-02 Benson James (Director) Sale 2,000 22.80 45,600
2017-09-06 Mackin James P (President & CEO) Sale 81,950 21.97 1,800,687
2017-09-05 Mackin James P (President & CEO) Sale 43,050 22.09 951,060
2017-09-05 Ronald C Elkins (Director) Sale 1,000 22.00 22,000
2017-06-27 Horton Amy (VP, Chief Accounting Officer) Sale 9,577 20.00 191,540
2017-06-27 Horton Amy (VP, Chief Accounting Officer) Option Ex 18,667 5.12 95,575
2017-02-22 Capps Scott B (VP, Clinical Research) Sale 11,083 16.40 181,772
2017-02-22 Capps Scott B (VP, Clinical Research) Option Ex 16,667 7.01 116,835
2016-09-12 Holloway Jean F (VP, General Counsel) Option Ex 3,000 9.64 28,920
2016-09-12 Gale David C (VP, Research & Development) Option Ex 3,000 7.01 21,030
2016-09-12 Lee David Ashley (Executive VP, COO & CFO) Option Ex 4,486 7.01 31,446
2016-09-09 Lee David Ashley (Executive VP, COO & CFO) Option Ex 28,847 7.01 202,217
2016-07-26 Horton Amy (VP, Chief Accounting Officer) Option Ex 10,000 7.01 70,100
2016-07-26 Ronald C Elkins (Director) Sale 2,000 14.00 28,000
2016-06-01 Mccall Ronald D (Director) Sale 10,000 11.56 115,600
2016-05-10 Benson James (Director) Sale 5,000 12.22 61,100
2016-04-15 Ronald C Elkins (Director) Sale 1,000 12.00 12,000
2016-03-07 Ronald C Elkins (Director) Sale 2,000 11.18 22,360
2016-03-04 Mackin James P (President & CEO) Buy 4,600 10.94 50,324
2016-03-03 Mackin James P (President & CEO) Buy 5,400 10.89 58,806
2016-02-19 Capps Scott B (VP, Clinical Research) Sale 15,000 10.30 154,500
2016-02-19 Capps Scott B (VP, Clinical Research) Option Ex 15,000 4.83 72,450
2016-02-18 Lee David Ashley (Executive VP, COO & CFO) Sale 8,000 10.13 81,040
2016-02-18 Lee David Ashley (Executive VP, COO & CFO) Option Ex 8,000 4.83 38,640
2016-02-17 Lee David Ashley (Executive VP, COO & CFO) Option Ex 12,700 4.83 61,341
2015-12-28 Lee David Ashley (Exec. VP, COO and CFO) Sale 700 11.00 7,700
2015-12-28 Lee David Ashley (Exec. VP, COO and CFO) Option Ex 1,000 4.83 4,830
2015-11-30 Lee David Ashley (Executive VP, COO & CFO) Sale 1,219 11.03 13,439
2015-11-30 Lee David Ashley (Executive VP, COO & CFO) Option Ex 5,219 4.83 25,207
2015-11-27 Lee David Ashley (Executive VP, COO & CFO) Sale 10,581 11.03 116,708
2015-11-27 Lee David Ashley (Executive VP, COO & CFO) Option Ex 10,581 4.83 51,106
2015-09-15 Benson James (Director) Sale 5,839 9.65 56,346
2015-09-11 Benson James (Director) Sale 3,359 9.65 32,414
2015-02-23 Anderson Steven G (Executive Chairman) Option Ex 63,750 9.73 620,287
2015-02-19 Anderson Steven G (Executive Chairman) Sale 30,000 10.93 327,960
2015-02-16 Fronk David (VP, Regulatory Affairs) Option Ex 15,000 9.73 145,950
2014-12-09 Anderson Bruce G. (VP, US Sales &Global Marketing) Sale 3,900 10.29 40,142
2014-12-09 Anderson Bruce G. (VP, US Sales &Global Marketing) Option Ex 3,900 8.37 32,642
2014-12-04 Lee David Ashley (Executive VP, COO & CFO) Option Ex 27,500 9.73 267,575
2014-12-02 Horton Amy (Chief Accounting Officer) Option Ex 9,000 9.73 87,570
2014-11-25 Anderson Bruce G. (VP, US Sales &Global Marketing) Sale 20,211 10.12 204,454
2014-11-25 Anderson Bruce G. (VP, US Sales &Global Marketing) Option Ex 20,211 6.27 126,662
2014-11-05 Ronald C Elkins (Director) Sale 4,000 10.08 40,320
2014-11-03 Benson James (Director) Sale 10,000 10.22 102,200
2014-09-08 Anderson Bruce G. (VP, US Sales and Marketing) Sale 10,000 10.05 100,530
2014-09-08 Anderson Bruce G. (VP, US Sales and Marketing) Option Ex 10,000 5.12 51,200
2014-09-02 Anderson Steven G (Chairman) Sale 20,000 10.07 201,500
2014-08-25 Anderson Bruce G. (VP, US Sales and Marketing) Sale 5,000 10.15 50,730
2014-08-25 Anderson Bruce G. (VP, US Sales and Marketing) Option Ex 5,000 5.12 25,600
2014-08-18 Anderson Bruce G. (VP, US Sales and Marketing) Sale 10,000 10.52 105,180
2014-08-18 Anderson Bruce G. (VP, US Sales and Marketing) Option Ex 10,000 4.83 48,300
2014-08-15 Burris Jeffrey W (Vice President & Gen. Counsel) Option Ex 5,000 7.00 35,000
2014-08-14 Lee David Ashley (Executive VP, COO & CFO) Sale 119 10.50 1,249
2014-08-14 Lee David Ashley (Executive VP, COO & CFO) Option Ex 119 9.73 1,157
2014-08-13 Burris Jeffrey W (Vice President & Gen. Counsel) Sale 11,000 10.50 115,500
2014-08-13 Burris Jeffrey W (Vice President & Gen. Counsel) Option Ex 11,000 5.12 56,320
2014-08-13 Lee David Ashley (Executive VP, COO & CFO) Sale 9,881 10.51 103,849
2014-08-13 Lee David Ashley (Executive VP, COO & CFO) Option Ex 9,881 9.73 96,142
2014-07-29 Ronald C Elkins (Director) Sale 2,500 9.67 24,175
2014-07-28 Anderson Bruce G. (VP, US Sales and Marketing) Sale 5,000 9.48 47,425
2014-07-28 Anderson Bruce G. (VP, US Sales and Marketing) Option Ex 5,000 4.83 24,150
2014-07-28 Anderson Steven G (President, CEO and Chairman) Sale 19,477 9.52 185,498
2014-06-09 Horton Amy (Chief Accounting Officer) Sale 2,500 9.26 23,152
2014-05-16 Fronk David (VP Reg. Affrs. and Qual Assur.) Sale 8,952 8.61 77,085
2014-05-13 Anderson Steven G (President, CEO and Chairman) Sale 1,300 9.00 11,703
2014-05-12 Anderson Steven G (President, CEO and Chairman) Sale 29,223 9.00 263,065
2014-05-06 Anderson Bruce G. (VP, US Sales and Marketing) Sale 14,047 8.81 123,754
2014-05-02 Anderson Bruce G. (VP, US Sales and Marketing) Sale 2,823 8.95 25,274
2014-02-18 Horton Amy (Chief Accounting Officer) Option Ex 2,250 8.70 19,575
2013-12-30 Anderson Steven G (President, CEO and Chairman) Option Ex 63,750 8.70 554,625
2013-11-27 Capps Scott B (VP-Clinical Research) Sale 25,000 10.60 265,100
2013-11-27 Capps Scott B (VP-Clinical Research) Option Ex 25,000 9.06 226,500
2013-11-26 Burris Jeffrey W (Vice President & Gen. Counsel) Sale 5,000 10.50 52,500
2013-11-26 Burris Jeffrey W (Vice President & Gen. Counsel) Option Ex 5,000 7.00 35,000
2013-11-12 Fronk David (VP Reg. Affrs. and Qual Assur.) Sale 9,442 9.92 93,626
2013-11-11 Gale David C (VP-Research and Development) Sale 150 9.97 1,495
2013-11-11 Burris Jeffrey W (Vice President & Gen. Counsel) Sale 5,000 10.00 50,000
2013-11-11 Burris Jeffrey W (Vice President & Gen. Counsel) Option Ex 5,000 7.00 35,000
2013-11-11 Fronk David (VP Reg. Affrs. and Qual Assur.) Option Ex 10,132 8.70 88,148
2013-11-08 Fronk David (VP Reg. Affrs. and Qual Assur.) Option Ex 4,868 8.70 42,351
2013-11-07 Anderson Steven G (President, CEO and Chairman) Sale 23,375 9.47 221,454
2013-11-06 Anderson Steven G (President, CEO and Chairman) Sale 31,121 9.30 289,518
2013-11-05 Anderson Steven G (President, CEO and Chairman) Sale 45,504 9.39 427,237
2013-11-04 Burris Jeffrey W (Vice President & Gen. Counsel) Sale 5,000 9.53 47,650
2013-11-04 Burris Jeffrey W (Vice President & Gen. Counsel) Option Ex 5,000 7.00 35,000
2013-11-04 Lee David Ashley (Exec. VP, COO and CFO) Sale 11,909 9.65 114,957
2013-11-04 Lee David Ashley (Exec. VP, COO and CFO) Option Ex 12,500 8.70 108,749
2013-11-01 Horton Amy (Chief Accounting Officer) Option Ex 6,750 8.70 58,724
2013-10-29 Burris Jeffrey W (Vice President & Gen. Counsel) Sale 5,000 9.00 45,000
2013-10-29 Burris Jeffrey W (Vice President & Gen. Counsel) Option Ex 5,000 7.00 35,000
2013-10-29 Lee David Ashley (Exec. VP, COO and CFO) Option Ex 25,000 8.70 217,499
2013-10-29 Ronald C Elkins (Director) Sale 2,000 9.00 18,000
2013-08-27 Anderson Bruce G. (VP, US Sales and Marketing) Sale 4,500 6.33 28,462
2013-08-08 Horton Amy (Chief Accounting Officer) Sale 2,500 7.07 17,675
2013-08-05 Ronald C Elkins (Director) Sale 2,000 7.02 14,042
2013-08-01 Mccall Ronald D (Director) Sale 6,000 7.10 42,588
2013-07-12 Burris Jeffrey W (Vice President & Gen. Counsel) Option Ex 7,500 4.83 36,225
2013-06-06 Mccall Ronald D (Director) Sale 2,000 6.15 12,300
2013-06-05 Mccall Ronald D (Director) Sale 2,000 6.19 12,380
2013-05-31 Ronald C Elkins (Director) Sale 2,250 6.15 13,830
2012-11-30 Seery Gerald B (Sr. VP, Sales and Marketing) Sale 4,360 5.94 25,907
2012-11-14 Mccall Ronald D (Director) Sale 6,000 5.72 34,320
2012-08-27 Ronald C Elkins (Director) Sale 3,000 5.34 16,032
2012-06-07 Salveson Jon W (Director) Buy 25,000 4.79 119,825
2012-06-01 Ronald C Elkins (Director) Sale 3,000 4.57 13,703
2012-05-30 Mccall Ronald D (Director) Sale 6,000 4.52 27,114
2012-05-29 Mccall Ronald D (Director) Sale 4,000 4.57 18,276
2012-05-21 Lee David Ashley (Exec. VP, COO and CFO) Buy 2,100 4.90 10,283
2012-02-21 Ronald C Elkins (Director) Sale 5,000 5.61 28,025
2012-02-07 Fronk David (VP Reg. Affrs. and Qual Assur.) Option Ex 18,883 5.79 109,426
2012-02-03 Seery Gerald B (Sr. VP, Sales and Marketing) Option Ex 21,300 5.79 123,433
2011-12-06 Ronald C Elkins (Director) Sale 3,000 4.56 13,679
2011-11-22 Mccall Ronald D (Director) Sale 10,000 4.35 43,500
2011-11-21 Lee David Ashley (Exec. VP, COO and CFO) Buy 4,000 4.36 17,440
2011-11-18 Anderson Steven G (President, CEO and Chairman) Sale 5,000 4.49 22,465
2011-08-19 Seery Gerald B (Sr. VP, Sales and Marketing) Option Ex 21,099 4.25 89,670
2011-08-15 Heacox Albert E (Sr. VP Research and Devl) Option Ex 15,450 4.25 65,662
2011-08-09 Anderson Steven G (President, CEO and Chairman) Option Ex 63,500 4.25 269,875
2011-07-26 Fronk David (VP Reg. Affrs. and Qual Assur.) Option Ex 13,760 4.25 58,480
2011-07-14 Seery Gerald B (Sr. VP, Sales and Marketing) Sale 101 6.00 606
2011-07-14 Seery Gerald B (Sr. VP, Sales and Marketing) Option Ex 101 4.25 429
2011-07-13 Seery Gerald B (Sr. VP, Sales and Marketing) Sale 300 6.00 1,800
2011-07-13 Seery Gerald B (Sr. VP, Sales and Marketing) Option Ex 300 4.25 1,275
2011-07-07 Horton Amy (Chief Accounting Officer) Option Ex 9,000 4.25 38,250
2011-07-07 Lee David Ashley (Exec. VP, COO and CFO) Option Ex 17,200 4.25 73,100
2011-05-05 Bevevino Daniel J (Director) Sale 10,000 5.37 53,700
2011-05-05 Bevevino Daniel J (Director) Option Ex 10,000 5.00 50,000
2011-05-05 Ronald C Elkins (Director) Sale 4,000 5.41 21,620
2011-05-04 Benson James (Director) Sale 10,000 5.43 54,290
2011-05-04 Benson James (Director) Option Ex 10,000 5.00 50,000
2011-05-03 Ackerman Thomas F (Director) Sale 10,000 5.53 55,300
2011-05-03 Ackerman Thomas F (Director) Option Ex 10,000 5.00 50,000
2011-04-26 Anderson Steven G (President, CEO and Chairman) Option Ex 10,000 5.03 50,300
2011-04-13 Mccall Ronald D (Director) Option Ex 3,200 5.00 16,000
2010-11-15 Mccall Ronald D (Director) Sale 3,000 5.81 17,430
2010-11-12 Mccall Ronald D (Director) Sale 7,000 5.89 41,237
2010-11-12 Ronald C Elkins (Director) Sale 2,000 6.00 12,010
2010-03-01 Fronk David (VP Reg. Affrs. and Qual Assur.) Sale 7,500 7.01 52,582
2009-11-04 Heacox Albert E (Sr. VP Research and Devl) Option Ex 6,000 5.36 32,160
2009-09-15 Lee David Ashley (Exec. VP, COO and CFO) Option Ex 6,000 5.36 32,160
2009-09-09 Ronald C Elkins (Director) Sale 500 8.11 4,052
2009-08-25 Lee David Ashley (Exec. VP, COO and CFO) Option Ex 12,190 4.80 58,572
2009-08-24 Lee David Ashley (Exec. VP, COO and CFO) Sale 26,800 7.95 213,113
2009-08-24 Lee David Ashley (Exec. VP, COO and CFO) Option Ex 16,610 4.25 70,592
2009-08-21 Horton Amy (Chief Accounting Officer) Sale 2,000 8.15 16,300
2009-08-21 Horton Amy (Chief Accounting Officer) Option Ex 8,838 5.36 47,371
2009-08-21 Mccall Ronald D (Director) Sale 5,000 8.00 40,000
2009-08-20 Anderson Steven G (President, CEO and Chairman) Option Ex 10,000 5.36 53,600
2009-08-19 Fronk David (VP Reg. Affrs. and Qual Assur.) Option Ex 6,000 5.36 32,160
2009-08-18 Ronald C Elkins (Director) Sale 1,500 7.17 10,755
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of CRY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cryolife Inc (symbol CRY, CIK number 784199) see the Securities and Exchange Commission (SEC) website.